Pardes Biosciences, Inc. (PRDS): Price and Financial Metrics
PRDS Price/Volume Stats
| Current price | $2.16 | 52-week high | $3.93 |
| Prev. close | $2.16 | 52-week low | $0.75 |
| Day low | $2.13 | Volume | 2,378,900 |
| Day high | $2.20 | Avg. volume | 359,530 |
| 50-day MA | $2.03 | Dividend yield | N/A |
| 200-day MA | $1.70 | Market Cap | 133.95M |
PRDS Stock Price Chart Interactive Chart >
Pardes Biosciences, Inc. (PRDS) Company Bio
Pardes Biosciences, Inc., a pre-clinical stage biotechnology company, engages in developing oral direct acting antivirals. Its antivirals target viral main cysteine protease, an essential viral protein required for coronaviruses to replicate. Pardes Biosciences, Inc. was incorporated in 2020 and is based in Carlsbad, California.
PRDS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -84.72% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -89.68% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...